Avoiding Undertreatment, Overtreatment in Geriatric Breast Cancer Patients

Video

This video reviews how to ensure that older breast cancer patients are receiving the most appropriate care and highlights population studies that can help inform individual treatment decisions.

A paradox exists in the treatment of older breast cancer patients. This population has a higher risk of dying from their breast cancer and in many cases patients are being undertreated, as some can safely receive more effective treatments based on their specific disease characteristics.

But older patients also have a higher risk of dying from other causes compared with younger populations, and the risk of overtreatment is a serious consideration.

In this video, Hans Wildiers, MD, PhD, of University Hospitals Leuven in Belgium, discusses how to ensure that these patients are receiving the most appropriate care and highlights population studies that can help inform individual treatment decisions.

Related Videos
A panel of 4 experts on multiple myeloma
Data from the REVEAL study affirm elevated white blood cell counts and higher variant allele frequency as risk factors for progression in polycythemia vera.
Video 1 - 4 KOLs are featured in "Triaging and Prioritizing Patients with Multiple Myeloma"
Video 1 - 4 KOLs are featured in "CAR T-Cell Therapy: Leukapheresis Practices"
A panel of 4 experts on multiple myeloma
A panel of 4 experts on multiple myeloma
Additional analyses of patient-reported outcomes and MRD status in the QuANTUM-First trial are also ongoing, says Harry P. Erba, MD, PhD.
Overall survival data with blinatumomab in the phase 3 E1910 study may be an “important development” in CD19-positive B-ALL.
Intraoperative radiation therapy may allow surgical and radiation oncologists to collaboratively visualize at-risk areas in patients with cancer.
Positive margin rates have not appeared to improve for patients with cancer undergoing surgical care based on several prior studies.
Related Content